×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session2
Session Chair(s)
Goshi Ozawa, MS
Representative Director & President, Japan / R&D Head
Juniper Therapeutix K.K., Japan
Takashi Moriya, PhD, MBA
Director, VEO Vaccines Value Evidence and Outcomes, Japan MA
GlaxoSmithKline K.K., Japan
Speaker(s)
Session 2 - Presentation 1
Yumiko Miyazaki, MSc
Eli Lilly Japan K.K., Japan
Manager, Clinical Innovations & Business Integration,
Session 2 - Presentation 2
Teppei Sakano
Allm Inc., Japan
Group CEO
Session 2 - Presentation 3
Yoshinori Abe, MD
Ubie Inc., Japan
Co-funder
Session 2 - Presentation 4
Shinya Yamamoto, PhD
Link & Innovation, Inc., Japan
Founder & CEO
Session 2 - Presentation 5
Norio Nakata, MD
The Jikei University School of Medicine, Japan
Associate Professor, Department of Radiology